| |
| |
|
| Insider
Information: |
Cavazza Paolo |
| Relationship: |
10% Owner |
| City: |
Lugano |
| State: |
V8 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
10,656,982 |
|
|
Indirect Shares
|
18,340,916 |
|
|
| Direct
Value |
$476,546 |
|
|
|
Indirect Value
|
$1,328,416 |
|
|
| Total
Shares |
28,997,898 |
|
|
| Total
Value |
$1,804,962 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -31.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sciclone Pharmaceuticals Inc |
SCLN |
10% Owner |
2008-01-30 |
822,815 |
2008-01-30 |
8,635,831 |
Premium* |
|
|
Questcor Pharmaceuticals Inc |
QCOR |
10% Owner |
2005-04-15 |
8,643,397 |
2005-04-15 |
4,922,156 |
Premium* |
|
|
Regenerx Biopharmaceuticals Inc |
RGN |
10% Owner |
|
0 |
2021-06-30 |
1,500,000 |
Premium* |
|
|
Soligenix Inc Common |
SNGX |
10% Owner |
2010-06-18 |
1,190,770 |
2010-06-18 |
3,282,929 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2021-06-30 |
4 |
B |
$0.20 |
$300,000 |
I/I |
1,500,000 |
1,500,000 |
1.5 |
% |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2011-01-05 |
4 |
B |
$0.27 |
$600,000 |
I/I |
2,222,223 |
12,937,111 |
1.5 |
- |
|
| SNGX |
Soligenix Inc Common |
10% Owner |
– – • |
2010-06-18 |
4 |
B |
$0.21 |
$2,364,759 |
I/I |
11,535,409 |
3,282,929 |
1.5 |
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2010-05-21 |
4 |
B |
$0.00 |
$0 |
I/I |
240,000 |
240,000 |
1.42 |
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2009-10-08 |
4 |
B |
$0.82 |
$1,000,000 |
I/I |
1,219,512 |
8,175,110 |
1.5 |
- |
|
| SNGX |
Soligenix Inc Common |
10% Owner |
– – • |
2009-09-24 |
4 |
B |
$0.25 |
$1,000,000 |
I/I |
3,952,569 |
45,619,236 |
1.5 |
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2009-06-02 |
4 |
B |
$0.40 |
$125,000 |
I/I |
312,500 |
6,955,598 |
1.5 |
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2009-04-13 |
4 |
B |
$0.57 |
$600,000 |
I/I |
1,052,631 |
6,643,098 |
1.5 |
- |
|
| SNGX |
Soligenix Inc Common |
10% Owner |
– – • |
2009-02-11 |
4 |
B |
$0.18 |
$4,500,000 |
I/I |
25,000,000 |
41,666,667 |
1.5 |
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2008-12-10 |
4 |
B |
$1.45 |
$1,499,999 |
I/I |
1,034,482 |
5,590,467 |
1.5 |
- |
|
| SNGX |
Soligenix Inc Common |
10% Owner |
– – • |
2008-11-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,190,770 |
|
- |
|
| SNGX |
Soligenix Inc Common |
10% Owner |
– – • |
2008-11-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
17,022,767 |
|
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2008-02-29 |
4 |
B |
$1.00 |
$2,500,000 |
I/I |
2,500,000 |
4,555,985 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2008-01-30 |
4 |
B |
$2.05 |
$58,604 |
I/I |
28,600 |
6,580,938 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2008-01-28 |
4 |
B |
$2.05 |
$820 |
I/I |
400 |
6,552,338 |
1.42 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2008-01-25 |
4 |
B |
$2.04 |
$65,615 |
I/I |
32,087 |
6,551,938 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2008-01-24 |
4 |
B |
$2.05 |
$8,610 |
I/I |
4,200 |
6,519,851 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2008-01-23 |
4 |
B |
$2.01 |
$44,481 |
I/I |
22,098 |
6,515,651 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2008-01-22 |
4 |
B |
$2.01 |
$14,149 |
I/I |
7,035 |
6,493,553 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2008-01-16 |
4 |
B |
$2.02 |
$24,974 |
I/I |
12,353 |
6,486,718 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2008-01-15 |
4 |
B |
$2.01 |
$102,579 |
I/I |
50,976 |
6,474,365 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2008-01-14 |
4 |
B |
$2.00 |
$800 |
I/I |
400 |
6,423,389 |
1.42 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2008-01-14 |
4/A |
B |
$2.00 |
$400 |
I/I |
200 |
6,423,189 |
1.42 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2008-01-11 |
4 |
B |
$2.00 |
$55,982 |
I/I |
28,001 |
6,422,989 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2007-11-13 |
4 |
B |
$2.04 |
$111,575 |
I/I |
54,640 |
6,394,988 |
1.5 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
